A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)

European Heart Journal

Volumn 36, Issue 34, 2015, Pages 2297-2309

  Anker, Stefan D ^a   Coats, Andrew J S ^b,c   Cristian, Gabriel ^d   Dragomir, Dinu ^e   Pusineri, Enrico ^f   Piredda, Massimo ^f   Bettari, Luca ^g   Dowling, Robert ^h   Volterrani, Maurizio ⁱ   Kirwan, Bridget Anne ^j   Filippatos, Gerasimos ^k   Mas, Jean Louis ^l   Danchin, Nicolas ^m   Solomon, Scott D ⁿ   Lee, Randall J ^o   Ahmann, Frank ^p   Hinson, Andy ^p   Sabbah, Hani N ^q   Mann, Douglas L ^r  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d Central Military Hospital Bucharest   (Romania)

^e Spitalul Clinic de Urgen Bucure ti   (Romania)

^f IRCCS POLICLINICO SAN DONATO   (Italy)

^g CREMONA HOSPITAL   (Italy)

^h Dowling Consulting Inc   (United States)

ⁱ IRCCS SAN RAFFAELE PISANA   (Italy)

^j SOCAR RESEARCH SA   (Switzerland)

^k Second Department of Radiology   (Greece)

^l UNIVERSITÉ PARIS DESCARTES   (France)

^m HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

ⁿ HARVARD MEDICAL SCHOOL   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p LoneStar Heart Inc   (United States)

^q HENRY FORD HEALTH SYSTEM   (United States)

^r BARNES JEWISH HOSPITAL   (United States)

more..

Author keywords

Advanced chronic heart failure; Alginate hydrogel; Exercise capacity; Safety; Symptoms

Indexed keywords

ALGINIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIAC AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MINERALOCORTICOID ANTAGONIST; GLUCURONIC ACID; HEXURONIC ACID; HYDROGEL;

ADULT; AGED; ALGINATE HYDROGEL IMPLANT; ARTICLE; BODY SURFACE; CARDIAC IMPLANT; CARDIAC PATIENT; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEVICE SAFETY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITORING; HUMAN; HYDROGEL; INJECTABLE IMPLANT; MALE; MULTICENTER STUDY; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURGICAL MORTALITY; THORACOTOMY; ADMINISTRATION AND DOSAGE; CLINICAL TRIAL; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; LENGTH OF STAY; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PATIENT SAFETY; PHYSIOLOGY; PROSTHESES AND ORTHOSES; TREATMENT OUTCOME; WALKING;

ALGINATES; ECHOCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; GLUCURONIC ACID; HEART FAILURE; HEXURONIC ACIDS; HUMANS; HYDROGEL; LENGTH OF STAY; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PATIENT SAFETY; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; QUALITY OF LIFE; TREATMENT OUTCOME; WALKING;

EID: 84941242247     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv259     Document Type: Article

References (25)

1. McMurray JJ, Stewart S. Heart failure: epidemiology, aetiology, and prognosis of heart failure. Heart 2000;83:596-602.
2. Chen J, Normand SL, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for medicare beneficiaries, 1998-2008. JAMA 2011;306:1669-1678.
3. Mihardja SS, Gonzales JA, Gao D, Sievers RE, Fang Q, Stillson CA, Yu J, Peng M, Lee RJ. The effect of a peptide-modified thermo-reversible methylcellulose on wound healing and LV function in a chronic myocardial infarction rodent model. Biomaterials 2013;34:8869-8877.
4. Song M, Jang H, Lee J, Kim JH, Kim SH, Sun K, Park Y. Regeneration of chronic myo-cardial infarction by injectable hydrogels containing stem cell homing factor SDF-1 and angiogenic peptide Ac-SDKP. Biomaterials 2014;35:2436-2445.
5. Ungerleider JL, Christman KL. Concise review: injectable biomaterials for the treatment of myocardial infarction and peripheral artery disease: translational challenges and progress. Stem Cells Transl Med 2014;3:1090-1099.
6. Yu J, Christman KL, Chin E, Sievers RE, Saeed M, Lee RJ. Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J Thorac Cardiovasc Surg 2009;137:180-187.
7. Sabbah HN, Wang M, Gupta RC, Rastogi S, Ilsar I, Sabbah MS, Kohli S, Helgerson S, Lee RJ. Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure. JACC Heart Fail 2013;1:252-258.
8. TM with coronary artery bypass grafting reduces left ventricular wall stress and improves function in the failing human heart. Int J Cardiol 2013;168:2022-2028.
9. Mann DL, Acker MA, Jessup M, Sabbah HN, Starling RC, Kubo SH, Acorn Trial Principal Investigators and Study Coordinators. Clinical evaluation of the CorCap cardiac support device in patients with dilated cardiomyopathy. Ann Thorac Surg 2007; 84:1226-1235.
10. Grossi EA, Patel N, Woo YJ, Goldberg JD, Schwartz CF, Subramanian V, Feldman T, Bourge R, Baumgartner N, Genco C, Goldman S, Zenati M, Wolfe JA, Mishra YK, Trehan N, Mittal S, Shang S, Mortier TJ, Schweich CJ Jr, RESTOR-MV Study Group. Outcomes of the RESTOR-MV trial (randomized evaluation of a surgical treatment for off-pump repair of the mitral valve). J Am Coll Cardiol 2010;56:1984-1993.
11. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur Heart J 2012;33:1787-1847.
12. Cowie MR, Anker SD, Cleland JG, Felker GM, Filippatos F, Jaarsma T, Jourdain P, Knight E, Massie B, Ponikowski P, López-Sendón J. Improving care for patients with acute heart failure: before, during and after hospitalization. ESC Heart Failure 2014;1:110-145.
13. Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, Jaarsma T, Krum H, Rastogi V, Rohde LE, Samal UC, Shimokawa H, Siswanto BB, Sliwa K, Filippatos G. Heart failure: preventing disease and death worldwide. ESC Heart Failure 2014;1:4-25.
14. Sarullo FM, Fazio G, Brusca I, Fasullo S, Paterna S, Licata P, Novo G, Novo S, Di Pasquale P. Cardiopulmonary exercise testing in patients with chronic heart failure: prognostic comparison from peak VO2 and VE/VCO2 slope. Open Cardiovasc Med J 2010;4:127-134.
15. 2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training. Circ Heart Fail 2012;5:579-585.
16. Cahalin L, Mathier M, Semigran M, Dec G, DiSalvo T. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 1996;110:325-332.
17. Roul G, Germain P, Bareiss P. Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am Heart J 1998;136: 449-457.
18. Shah MR, Hasselblad V, Gheorghiade M, Adams KF, Swedberg K, Califf RM, O'Connor CM. Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomy-opathy. Am J Cardiol 2001;88:987e93.
19. Perera S, Mody S, Woodman R, Studenski S. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatrics Soc 2006; 54:743-749.
20. Ingle L, Shelton RJ, Rigby AS, Nabb S, Clark AL, Cleland JG. The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure. Eur Heart J 2005;26:1742-1751.
21. Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh T, Parkhomenko A, Tavazzi L, Levesque V, Mori C, Roubert B, Filippatos G, Ruschitzka F, Anker SD, CONFIRM-HF Investigators. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J 2015;36:657-668.
22. Costanzo MR, Ivanhoe RJ, Kao A, Anand IS, Bank A, Boehmer J, Demarco T, Hergert CM, Holcomb RG, Maybaum S, Sun B, Vassiliades TA Jr, Rayburn BK, Abraham WT. Prospective evaluation of elastic restraint to lessen the effects of heart failure (PEERLESS-HF) trial. J Card Fail 2012;18:446-458.
23. Cardiokinetics Parachute Mazzaferri EL Jr, Gradinac S, Sagic D, Otasevic P, Hasan AK, Goff TL, Sievert H, Wunderlich N, Nikolic SD, Abraham WT. Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: results of the PercutAneous Ventricular RestorAtion in Chronic Heart failure Patients Trial. Am Heart J 2012;163:812-820.
24. Cheng Y, Aboodi MS, Wechsler AS, Kaluza GL, Granada JF, Van Bladel K, Annest LS, Yi GH. Epicardial catheter-based ventricular reconstruction: a novel therapy for is-chaemic heart failure with anteroapical aneurysm. Interact Cardiovasc Thorac Surg 2013;17:915-922.
25. Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL, STICH Hypothesis 2 Investigators. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009;360:1705-1717.